Roschier advised Elekta in its acquisition of Kaiku Health
Precision radiation medicine company Elekta AB has acquired 100% of Finnish tech company Kaiku Health Oy. Roschier advised Elekta in the transaction.
Through the acquisition of Kaiku Health, Elekta will further develop its focus on cancer care providers and their patients.
Kaiku Health Oy is best known for its app that monitors patient-reported outcomes, providing intelligent symptom tracking and management for healthcare providers in routine oncology care and studies. The Kaiku Health platform is in clinical routine use in over 40 cancer clinics and hospitals all over Europe.
Leading precision radiation medicine company Elekta AB (publ) is headquartered in Stockholm and listed on NASDAQ Stockholm. With more than 4 000 employees worldwide, Elekta is committed to ensuring that patients with cancer have access to precise, personalized radiotherapy treatments.
Roschier’s core advisory team comprised Tero Jormanainen, Johanna Lilja, Johannes Strang, Sonja Heiskala, Eveliina Pekkala and Sampsa Pekkinen.